Status:
COMPLETED
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
Lead Sponsor:
University of Guelph
Collaborating Sponsors:
Ontario Ministry of Agriculture, Food and Rural Affairs
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
Omega 3 fatty acids have been shown to provide a number of cardiometabolic benefits in both healthy and at risk populations. Specifically, the daily consumption of fish oil supplements has been report...
Detailed Description
Cardiovascular disease (CVD) and type 2 diabetes (T2D) are major contributors to healthcare costs in Canada. A cluster of cardiometabolic risk factors including insulin resistance, dyslipidemia, hyper...
Eligibility Criteria
Inclusion
- Between the ages of 18-30 years
- Healthy
Exclusion
- Younger than 18 years
- Older than 30 years
- Allergic to fish and/or shellfish or gelatin
- High consumption of omega-3 fats (either fatty fish or dietary supplements)
- Chronic or communicable diseases
- Anticipated change in lifestyle (moving to a new house, starting a new fitness routine).
- Discomfort giving blood
- Use of lipid-controlling medication, including cholesterol lowering drugs (statins), fatty acid/triglyceride altering (fibrates) or any other drug known to have lipid altering effects, such as ezetimibe, colesevelam, torcetrapib, avasimibe, and implitapide
- Chronic use of anti-inflammatory medications
- Pregnant, or is planning to become pregnant during the study
Key Trial Info
Start Date :
January 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2017
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03378232
Start Date
January 5 2017
End Date
May 30 2017
Last Update
February 20 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.